In BC cell lines, studies by others have shown that have shown that GATA3 and FOXA1 cooperate with PPARγ activation to drive the differentiation of a basal bladder cancer subtype to a more differentiated luminal subtype [23]. The gene discussed is FOXA1; the disease is urinary bladder cancer.